跳至主要内容
临床试验/CTRI/2025/02/080928
CTRI/2025/02/080928尚未招募不适用

Comparison of nebulized Dexmedetomidine and nebulized Midazolam as premediction for brain MRI in children with developmental delay prospective randomised control double blind trial

NA1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年2月26日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
NA
入组人数
90
试验地点
1
主要终点
Parental separation anxiety score.

研究概览

简要总结

Comparing nebulized dexmedetomidine versus nebulized Midazolam as premediction for brain MRI in children with developmental delay. It is a randomized double-blind study. Dexmedetomidine 1 microgm per kg and midazolam 0.2 mg per kg used.  Intravenous access secured after application of lignocaine.  Propofol infusion kept at 75 to 150 microgm per kg per minute after a bolus of 2 mg per kg for 10 minutes. Oxygen via simple face mask used.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
3.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Children with developmental delay for brain MRI.

排除标准

  • ASA 4,5 Age less than 2 and more than 12 Recent respiratory infection and cardiac disease Emergency MRI BMI more than 35 Parental refusal.

结局指标

主要结局

Parental separation anxiety score.

时间窗: 30 minutes after nebulization, at receiving child for induction of anesthesia.

次要结局

  • Ease of venepuncture(Total dose of propofol)

研究者

发起方
NA
申办方类型
Other [na]
责任方
Principal Investigator
主要研究者

Dr Tanushree Mohan

Sree Chitra Tirunal Institute of medical Sciences and Technology

研究点 (1)

Loading locations...

相似试验